Загрузка...
Could valproic acid be an effective anticancer agent? The evidence so far
Valproic acid is an inhibitor of class I histone deacetylases. Epigenetic therapies in cancer have been focus of a keen interest and HDAC inhibitors in particular have been approved for certain types of hematologic malignancies. Valproic acid is an attractive candidate for cancer therapy due to its...
Сохранить в:
| Опубликовано в: : | Expert Rev Anticancer Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579528/ https://ncbi.nlm.nih.gov/pubmed/25017212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.940329 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|